Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-08-29

Clinical Trial Update: Determining Optimal Treatment Sequences in Anxious Depression (DOTS-AD) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial DOTS-AD evaluating optimal treatment sequences for anxious depression; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Cincinnati | Conditions: Anxious Depression, Depression | Phase 4 | Status: RECRUITING